תוצאות חיפוש - Paul B. Robbins

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment

    Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment מאת Tina Krieger, Isobel Pearson, Judith A. Bell, Jim Doherty, Paul B. Robbins

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  2. 2
    Use of human tissue to assess the oncogenic activity of melanoma-associated mutations

    Use of human tissue to assess the oncogenic activity of melanoma-associated mutations מאת Yakov Chudnovsky, Amy E. Adams, Paul B. Robbins, Qun Lin, Paul A. Khavari

    יצא לאור 2005
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  3. 3
    <i>In vivo</i> restoration of laminin 5 β3 expression and function in junctional epidermolysis bullosa

    <i>In vivo</i> restoration of laminin 5 β3 expression and function in junctional epidermolysis bullosa מאת Paul B. Robbins, Qun Lin, Julia B. Goodnough, Hongsheng Tian, Xinjian Chen, Paul A. Khavari

    יצא לאור 2001
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  4. 4
    Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells

    Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells מאת Paul B. Robbins, Dianne C. Skelton, Xiaojin Yu, Stephanie Halene, Earl H. Leonard, Donald B. Kohn

    יצא לאור 1998
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  5. 5
    Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells

    Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells מאת Paul B. Robbins, Xiaojin Yu, D M Skelton, Karen Pepper, R M Wasserman, Li Zhu, Donald B. Kohn

    יצא לאור 1997
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  6. 6
    PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics

    PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics מאת Margarita Udall, Maria L. Rizzo, Juliet Kenny, Jim Doherty, SueAnn Dahm, Paul B. Robbins, E.C. Faulkner

    יצא לאור 2018
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  7. 7
    A Phase I Multi-Arm Dose-Expansion Study of the Anti-Programmed Cell Death-Ligand-1 (Pd-L1) Antibody Medi4736: Preliminary Data

    A Phase I Multi-Arm Dose-Expansion Study of the Anti-Programmed Cell Death-Ligand-1 (Pd-L1) Antibody Medi4736: Preliminary Data מאת Neil H. Segal, Omid Hamid, W. Hwu, Christophe Massard, Marcus O. Butler, Scott Antonia, Andy Blake-Haskins, Paul B. Robbins, X. Li, Jim Vasselli, Samir N. Khleif

    יצא לאור 2014
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  8. 8
    Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma

    Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma מאת Marlon C. Rebelatto, Anita Midha, Amita Mistry, Constantine Sabalos, Nicole Schechter, Xia Li, Xiaoping Jin, Keith E. Steele, Paul B. Robbins, John A. Blake-Haskins, Jill Walker

    יצא לאור 2016
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  9. 9
    Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial

    Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial מאת Masatoshi Kudo, Kenta Motomura, Yoshiyuki Wada, Yoshitaka Inaba, Yasunari Sakamoto, Masayuki Kurosaki, Yoshiko Umeyama, Yoichi Kamei, Junichiro Yoshimitsu, Yosuke Fujii, Mana Aizawa, Paul B. Robbins, Junji Furuse

    יצא לאור 2021
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  10. 10
    Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors

    Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors מאת Kathryn C. Arbour, Jarushka Naidoo, Keith E. Steele, Ai Ni, André L. Moreira, Natasha Rekhtman, Paul B. Robbins, Joyson Karakunnel, Andreas Rimner, James Huang, Gregory J. Riely, Matthew D. Hellmann

    יצא לאור 2017
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  11. 11
    Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

    Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation מאת Giuseppe Masucci, Alessandra Cesano, Rachael E. Hawtin, Sylvia Janetzki, Jenny Zhang, Ilan R. Kirsch, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Streicher, Lisa H. Butterfield, Magdalena Thurin

    יצא לאור 2016
    קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  12. 12
    Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

    Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations מאת Kevin K. Dobbin, Alessandra Cesano, John Alvarez, Rachael E. Hawtin, Sylvia Janetzki, Ilan R. Kirsch, Giuseppe Masucci, Paul B. Robbins, Senthamil R. Selvan, Howard Streicher, Jenny Zhang, Lisa H. Butterfield, Magdalena Thurin

    יצא לאור 2016
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  13. 13
    HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study

    HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study מאת Vivek Naranbhai, Mathias Viard, Michael Dean, Stefan Groha, David A. Braun, Chris Labaki, Sachet A. Shukla, Yuko Yuki, Parantu K. Shah, Kevin M. Chin, Megan Wind‐Rotolo, Xinmeng Jasmine Mu, Paul B. Robbins, Alexander Gusev, Toni K. Choueiri, James L. Gulley, Mary Carrington

    יצא לאור 2021
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  14. 14
    Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial

    Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial מאת Toni K. Choueiri, James Larkin, Sumanta K. Pal, Robert J. Motzer, Brian I. Rini, B. Venugopal, B. Yа. Alekseev, Hideaki Miyake, Gwénaëlle Gravis, Mehmet Asım Bilen, Seetharaman Hariharan, A. Chudnovsky, Keith A. Ching, Xinmeng Jasmine Mu, Mariangela Mariani, Paul B. Robbins, Bo Huang, Alessandra di Pietro, Laurence Albigès

    יצא לאור 2021
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  15. 15
    Hallmarks of Resistance to Immune-Checkpoint Inhibitors

    Hallmarks of Resistance to Immune-Checkpoint Inhibitors מאת Maria Karasarides, Alexandria P. Cogdill, Paul B. Robbins, Michaela Bowden, Elizabeth M. Burton, Lisa H. Butterfield, Alessandra Cesano, Christian Hammer, Cara Haymaker, Christine E. Horak, Heather M. McGee, Anne Monette, Nils-Petter Rudqvist, Christine N. Spencer, Randy F. Sweis, Benjamin G. Vincent, Erik Wennerberg, Jianda Yuan, Roberta Zappasodi, Vanessa M. Hubbard Lucey, Daniel K. Wells, Theresa LaVallee

    יצא לאור 2022
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  16. 16
    Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

    Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial מאת Robert J. Motzer, Paul B. Robbins, Thomas Powles, Laurence Albigès, John B.A.G. Haanen, James Larkin, Xinmeng Jasmine Mu, Keith A. Ching, Motohide Uemura, Sumanta K. Pal, B. Yа. Alekseev, Gwénaëlle Gravis, Matthew T. Campbell, Konstantin Penkov, Jae‐Lyun Lee, Hariharan Subramanian, Xiao Wang, Weidong Zhang, Jing Wang, Aleksander Chudnovsky, Alessandra di Pietro, Amber C. Donahue, Toni K. Choueiri

    יצא לאור 2020
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  17. 17
    Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

    Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma מאת Robert J. Motzer, Konstantin Penkov, John B.A.G. Haanen, Brian I. Rini, Laurence Albigès, Matthew T. Campbell, Balaji Venugopal, Christian Kollmannsberger, Sylvie Négrier, Motohide Uemura, Jae L. Lee, Aleksandr Vasiliev, Wilson H. Miller, Howard Gurney, Manuela Schmidinger, James Larkin, Michael B. Atkins, Jens Bedke, B. Yа. Alekseev, Jing Wang, Mariangela Mariani, Paul B. Robbins, Aleksander Chudnovsky, Camilla Fowst, Hariharan Subramanian, Bo Huang, Alessandra di Pietro, Toni K. Choueiri

    יצא לאור 2019
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  18. 18
    Challenges to Using Big Data in Cancer

    Challenges to Using Big Data in Cancer מאת Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O’Brien, Paul B. Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava

    יצא לאור 2023
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  19. 19
    Case Studies for Overcoming Challenges in Using Big Data in Cancer

    Case Studies for Overcoming Challenges in Using Big Data in Cancer מאת Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O’Brien, Paul B. Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava

    יצא לאור 2023
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:

כלי חיפוש: